ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TOIIW Oncology Institute Inc

0.0197
0.0103 (109.57%)
After Hours
Last Updated: 23:11:01
Delayed by 15 minutes
Share Name Share Symbol Market Type
Oncology Institute Inc NASDAQ:TOIIW NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0103 109.57% 0.0197 0.0091 0.0198 0.012 0.0094 0.0119 62,852 23:11:01

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

05/11/2024 12:09am

GlobeNewswire Inc.


Oncology Institute (NASDAQ:TOIIW)
Historical Stock Chart


From Oct 2024 to Dec 2024

Click Here for more Oncology Institute Charts.

The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financial results after the market close on Wednesday, November 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13749308. The replay will be available until Wednesday, November 20, 2024.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors

Solebury Strategic Communicationsinvestors@theoncologyinstitute.com

1 Year Oncology Institute Chart

1 Year Oncology Institute Chart

1 Month Oncology Institute Chart

1 Month Oncology Institute Chart

Your Recent History

Delayed Upgrade Clock